Back to today’s briefing

Story perspectives

Avitia Launches Game-Changing Cancer Diagnostics Platform with $5M Investment

2/28/2025

39 9

Summary

Story summary

Montréal's Avitia has unveiled an innovative cancer diagnostics platform, backed by a $5 million seed investment from PacBridge Capital Partners, where CEO James Lumsdaine plays a key role. By harnessing machine learning and next-generation sequencing, Avitia is set to revolutionize cancer testing accessibility, drawing on technology from the former Imagia Canexia Health.

1 of 1

Story summary

Montréal's Avitia has unveiled an innovative cancer diagnostics platform, backed by a $5 million seed investment from PacBridge Capital Partners, where CEO James Lumsdaine plays a key role. By harnessing machine learning and next-generation sequencing, Avitia is set to revolutionize cancer testing accessibility, drawing on technology from the former Imagia Canexia Health.